News from scibase A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

12:09 GMT SciBase Holding AB Announces Changes in the Board

Thomas Eklund, member of the board, has announced that he resigns effective today from the Board of SciBase Holding AB at his own request. Thomas has ...


07:22 GMT SciBase: Interim Report

January 1 - September 30, 2019 The third quarter in figures Net sales amounted to TSEK 1,940 (1,359). The loss after tax amounted to TSEK 9,868...


12 Nov, 2019, 15:10 GMT SciBase Announces Order of Nevisense from Mount Sinai Hospital's New Melanoma Clinic

SciBase a leading developer of electrical impedance spectroscopy systems in dermatology, announced today that The Kimberly and Eric J. Waldman...


08 Nov, 2019, 14:42 GMT The Following People have been Appointed as Members of SciBase Holding's Nominating Committee for the Annual General Meeting in 2020

Frederick Johansson (representing SEB Venture Capital, Filip Petersson (SEB pensionsstiftelse), Christer Jönsson (Fouriertransform), Tord Lendau...


01 Nov, 2019, 07:10 GMT SciBase Receives Breakthrough Order From Large US Dermatology Group

SciBase today announces the first multi system order from a large dermatology practice group. Advanced Dermatology, P.C. is a group of over 40...


03 Sep, 2019, 14:10 BST SciBase Announces First Sale within the New Skin Barrier Application

SciBase today announces the first sale and shipment of SciBase products for the evaluation of skin barrier function. The first shipment is to a...


22 Aug, 2019, 07:21 BST SciBase: Interim Report

January 1 – June 30, 2019 The second quarter in figures Net sales amounted to TSEK 2,168 (1,571). The loss after tax amounted to TSEK 10,613 (10,298)....


16 May, 2019, 18:12 BST Bulletin from Annual General Meeting of SciBase Holding AB (publ) on 16 May 2019

At the annual general meeting of SciBase Holding AB (publ) on 16 May 2019 in Stockholm the shareholders adopted the below resolutions. Resolution...


10 May, 2019, 07:30 BST SciBase: Interim Report

The first quarter in figures Net sales amounted to TSEK 2,368 (1,939). The loss after tax amounted to TSEK 8,906 (9 656). The loss per share amounted ...


17 Apr, 2019, 07:13 BST New Study Opens up New Applications for SciBase's Product Nevisense

The Swiss Institute of Allergy and Asthma Research (SIAF) and SciBase announce today the publication of a breakthrough animal study within the area...


20 Feb, 2019, 11:32 GMT Correction Previously Distributed Press Release SciBase Holding AB (publ): Year-end Report 2018

January 1 – December 31, 2018 The fourth quarter in figures Net sales amounted to TSEK 2,030 (1,886). The loss after tax amounted to TSEK 11,506...


20 Feb, 2019, 07:17 GMT SciBase - Year-end report

January 1 – December 31, 2018 The fourth quarter in figures Net sales amounted to TSEK 2,030 (1,886). The loss after tax amounted to TSEK 11,506...


06 Dec, 2018, 07:14 GMT SciBase Announces Skin Barrier Testing Collaboration With Leading Swiss Research Center

SciBase and Swiss Institute of Allergy and Asthma Research, Davos Switzerland (SIAF-SFI) announced today the signing of a formal collaboration...


19 Nov, 2018, 14:43 GMT Clinical Guideline for Nevisense Published in Germany

A new clinical guideline supporting the use of Nevisense in the evaluation of lesions with suspicion of melanoma has been published in the German...


13 Nov, 2018, 07:19 GMT Interim report - SciBase

January 1 – September 30, 2018 The third quarter in figures Net sales amounted to TSEK 1,359 (1,172). The loss after tax including an extraordinary...


21 Aug, 2018, 07:57 BST SciBase: Interim Report

January 1 – June 30, 2018 The second quarter in figures Net sales amounted to TSEK 1,571 (2,046) The loss after tax amounted to TSEK 10,298 (11,746)...


21 Jun, 2018, 07:17 BST SciBase Releases Major Improvements to Nevisense

The previously announced breakthrough update to Nevisense, SciBase device for the early detection of melanoma, has now been released. "To be accepted ...


16 May, 2018, 18:09 BST Bulletin from Annual General Meeting of SciBase Holding AB (publ) on 16 May 2018

At the annual general meeting of SciBase Holding AB (publ) on 16 May 2018 in Stockholm the shareholders adopted the below resolutions. Resolution...


20 Feb, 2018, 07:15 GMT SciBase - Year-end Report

January 1 – December 31, 2017 The fourth quarter in figures Net sales amounted to TSEK 1,886 (1,935). The loss after tax amounted to TSEK 10,295...


10 Nov, 2017, 07:25 GMT SciBase: Interim Report

January 1 – September 30, 2017 The third quarter in figures Net sales amounted to TSEK 1,172 (1,580). The loss after tax amounted to TSEK 8,810...


09 Nov, 2017, 14:45 GMT SciBase Receives First Commercial Order in the U.S. From Private Clinic in New York

SciBase has received the first commercial order in the US - from a private clinic with a focus on self-pay patients in Manhattan, New York. The...


07 Nov, 2017, 15:25 GMT SciBase Receives Order of up to 1 Million SEK Within a New Customer Segment in Italy

SciBase has signed a new distribution agreement in Italy with International Health and Fitness Organisation AB (IHFO), a Swedish distributor active...


26 Oct, 2017, 21:14 BST Notice to Attend Extraordinary General Meeting in SciBase Holding AB (publ)

The shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company") are hereby invited to the extraordinary general meeting to be...


26 Oct, 2017, 21:06 BST SciBase Holding AB (publ) Proposes a Preferential Rights Issue of SEK 85 Million, Secured to SEK 75 Million

Summary The board of directors of SciBase Holding AB (publ) ("SciBase" or "The Company") has decided to propose a new share issue of approximately...


16 Oct, 2017, 07:56 BST Nevisense Presented as One of the Top Ten Most Important News Stories Within Skin Cancer for Dermatologists at US Congress

SciBase has participated in, exhibited and demonstrated their product Nevisense, for early detection of malignant melanoma at the Fall Clinical...